Subcutaneous oxyntomodulin reduces body weight in obese subjects
Diabetes · 2005 · PMID 15793252
Ver en PubMed →Oxyntomodulin improves glucose homeostasis via brain and liver
Endocrinology · 2005 · PMID 16249450
Ver en PubMed →Acute effects of oxyntomodulin on appetite
J Clin Endocrinol Metab · 2003 · PMID 14671200
Ver en PubMed →Synergistic metabolic effects of oxyntomodulin analogs
Obesity · 2008 · PMID 18490308
Ver en PubMed →Cotadutide for NAFLD and type 2 diabetes
Lancet Gastroenterol Hepatol · 2021 · PMID 34389611
Ver en PubMed →Retatrutide phase 2 weight-loss trial
N Engl J Med · 2023 · PMID 37326429
Ver en PubMed →STEP 1 semaglutide trial in obesity
N Engl J Med · 2021 · PMID 33595756
Ver en PubMed →Semaglutide cardiovascular outcomes (SUSTAIN-6)
N Engl J Med · 2016 · PMID 27633186
Ver en PubMed →Molecular design of semaglutide
J Med Chem · 2015 · PMID 25629528
Ver en PubMed →Semaglutide pharmacokinetics
Clin Pharmacokinet · 2017 · PMID 28246114
Ver en PubMed →SURMOUNT-1 tirzepatide trial
N Engl J Med · 2022 · PMID 36042316
Ver en PubMed →SURPASS program glycemic outcomes
N Engl J Med · 2021 · PMID 34449194
Ver en PubMed →Sci Transl Med cotadutide double agonist
Sci Transl Med · 2018 · PMID 30065351
Ver en PubMed →Triagonist peptide inspired by oxyntomodulin
Cell Metab · 2018 · PMID 29606395
Ver en PubMed →Oxyntomodulin and brown adipose activation
Cell Metab · 2014 · PMID 25264251
Ver en PubMed →Oxyntomodulin alleviates hepatic steatosis
Front Endocrinol · 2019 · PMID 31152184
Ver en PubMed →Incretin physiology and therapeutics
J Clin Endocrinol Metab · 2020 · PMID 32030442
Ver en PubMed →Safety of oxyntomodulin analog BI 456906
Diabetes Care · 2022 · PMID 35576462
Ver en PubMed →GLP-1/GCGR co-agonists for NAFLD
Diabetes Obes Metab · 2021 · PMID 33742492
Ver en PubMed →Neural correlates of satiety hormones
Diabetes · 2014 · PMID 24099642
Ver en PubMed →Exercise, appetite hormones and oxyntomodulin
Appetite · 2014 · PMID 25041073
Ver en PubMed →Hormonal predictors of weight-loss maintenance
Int J Obes · 2016 · PMID 27222143
Ver en PubMed →Physiology of glucagon and receptors
Nat Rev Endocrinol · 2018 · PMID 29795436
Ver en PubMed →FGF21 analogs for metabolic disease
J Clin Endocrinol Metab · 2020 · PMID 32030440
Ver en PubMed →PYY and oxyntomodulin co-secretion
Endocrinology · 2016 · PMID 26880730
Ver en PubMed →Retatrutide metabolic profile
Cell Metab · 2023 · PMID 37423325
Ver en PubMed →GLP-1 receptor distribution
Nat Rev Endocrinol · 2017 · PMID 28990586
Ver en PubMed →Combined amylin and GLP-1 therapy
Diabetes · 2019 · PMID 31147461
Ver en PubMed →Microbiota modulation of L-cells
Cell Host Microbe · 2017 · PMID 28552348
Ver en PubMed →